Daiwa Securities Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12
| Closed | – | – | 1319 |
|
|
2023
Q3 | $0 | Hold |
12
| – | – | ﹤0.01% | 1285 |
|
|
2023
Q2 | $0 | Sell |
12
-615
| -98% | – | ﹤0.01% | 1314 |
|
|
2023
Q1 | $45K | Buy |
627
+121
| +24% | +$8.68K | ﹤0.01% | 1046 |
|
|
2022
Q4 | $41K | Buy |
506
+56
| +12% | +$4.54K | ﹤0.01% | 1051 |
|
|
2022
Q3 | $43K | Sell |
450
-119
| -21% | -$11.4K | ﹤0.01% | 1066 |
|
|
2022
Q2 | $111K | Buy |
569
+557
| +4,642% | +$109K | ﹤0.01% | 1008 |
|
|
2022
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 1203 |
|
|
2021
Q4 | $5K | Hold |
12
| – | – | ﹤0.01% | 1183 |
|
|
2021
Q3 | $5K | Buy |
12
+6
| +100% | +$2.5K | ﹤0.01% | 1169 |
|
|
2021
Q2 | $2K | Hold |
6
| – | – | ﹤0.01% | 1130 |
|
|
2021
Q1 | $2K | Hold |
6
| – | – | ﹤0.01% | 1135 |
|
|
2020
Q4 | $3K | Sell |
6
-10
| -63% | -$5K | ﹤0.01% | 1076 |
|
|
2020
Q3 | $5K | Buy |
16
+4
| +33% | +$1.25K | ﹤0.01% | 1078 |
|
|
2020
Q2 | $3K | Hold |
12
| – | – | ﹤0.01% | 1119 |
|
|
2020
Q1 | $3K | Hold |
12
| – | – | ﹤0.01% | 1121 |
|
|
2019
Q4 | $5K | Sell |
12
-2
| -14% | -$833 | ﹤0.01% | 1093 |
|
|
2019
Q3 | $5K | Buy |
14
+2
| +17% | +$714 | ﹤0.01% | 1061 |
|
|
2019
Q2 | $6K | Hold |
12
| – | – | ﹤0.01% | 1065 |
|
|
2019
Q1 | $12K | Buy |
12
+4
| +50% | +$4K | ﹤0.01% | 1011 |
|
|
2018
Q4 | $7K | Hold |
8
| – | – | ﹤0.01% | 1010 |
|
|
2018
Q3 | $9K | Hold |
8
| – | – | ﹤0.01% | 1031 |
|
|
2018
Q2 | $8K | Hold |
8
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q1 | $8K | Buy |
+8
| New | +$8K | ﹤0.01% | 1034 |
|